Pharma-Bio Serv, Inc.
PBSV
$0.51
-$0.09-15.00%
OTC PK
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.20% | 5.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.20% | 5.91% | |||
| Cost of Revenue | -6.16% | 6.01% | |||
| Gross Profit | 6.59% | 5.71% | |||
| SG&A Expenses | 6.59% | -2.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.88% | 3.06% | |||
| Operating Income | -6.62% | 40.17% | |||
| Income Before Tax | 940.21% | 165.54% | |||
| Income Tax Expenses | 400.00% | 103.55% | |||
| Earnings from Continuing Operations | 1,022.35% | -47.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,022.35% | -47.20% | |||
| EBIT | -6.62% | 40.17% | |||
| EBITDA | 3.99% | 44.13% | |||
| EPS Basic | 950.00% | -42.86% | |||
| Normalized Basic EPS | 800.00% | 175.00% | |||
| EPS Diluted | 900.00% | -42.86% | |||
| Normalized Diluted EPS | 800.00% | 175.00% | |||
| Average Basic Shares Outstanding | -0.10% | -0.06% | |||
| Average Diluted Shares Outstanding | -0.07% | -0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||